Investor mix
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 2 | 33% |
| Other / undisclosed | 1 | 17% |
CRO focused on development of invitro diagnostic reagents
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Private equity | 2 | 33% |
| Other / undisclosed | 1 | 17% |